ZY-19489: Clinical Trials

2 trials of ZY-19489, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Unknown 1

Follow ZY-19489: new trials by email Literature Review of ZY-19489 trials Research Report on ZY-19489

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers
ZY19489 + Ferroquine (FQ), Placebo - Uncomplicated Malaria, Asymptomatic Condition
Phase 1UnknownZydus Lifesciences Limited362024-08-302024-10-01
A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjects
ZY19489 Capsule, Placebo Capsule - Malaria
Phase 1CompletedZydus Lifesciences Limited242021-08-252022-07-11

Conditions studied

Asymptomatic Diseases (1)  ·  Malaria (1)  ·  Malaria, Falciparum (1)

Sponsors

Zydus Lifesciences Limited (2)

Countries

Gabon (1)  ·  India (1)

Top investigators

Dr Deven Parmar, MD (1)  ·  Dr. Deven Parmar, MD,FCP (1)